Cancer Genetics Laboratory, Department of Biochemistry
Parry is a Principal Investigator in the Cancer Genetics Laboratory and the Chief Scientific Officer of Pacific Edge Biotechnology Ltd.
He completed his MSc at Otago in 1983, and his PhD at Cambridge University in 1989.
His research interests include the genetics of inherited cancers, in particular stomach cancer and the application of gene expression profiling to the development of diagnostic and prognostic tools for the better management of cancer.
Teaching
Parry teaches in GENE 313 Medical Genetics.
Recent publications
Guilford, P., Blair, V., More, H. & Humar, B. A short guide to hereditary diffuse gastric cancer. Heredity Cancer in Clinical Practice 5, 183-194 (2007).
Holyoake, A., Guilford, P. et al. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder. Clinical Cancer Research 14, 742-749 (2008).
Humar, B., Guilford, P. et al.E-Cadherin Deficiency Initiates Gastric Signet-Ring Cell Carcinoma in Mice and Man. Cancer Research 69, 2050-2056 (2009).
Humar, B. & Guilford, P. Hereditary diffuse gastric cancer and lost cell polarity: a short path to cancer. Future Oncology 4, 229-239 (2008).
John, T., Guilford, P. et al. Predicting clinical outcome through molecular profiling in stage III melanoma. Clinical Cancer Research 14, 5173-5180 (2008).
Kawanishi, H., Guilford, P. et al. Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. Clinical Cancer Research 14, 2579-2587 (2008).
Kwak, M.K., Guilford, P. et al. Expression of Kruppel-like factor 5 in human gastric carcinomas. Journal of Cancer Research and Clinical Oncology 134, 163-167 (2008).
Linger, R., Guilford, P. et al. Analysis of the DNDI gene in men with sporadic and familial testicular germ cell tumors. Genes Chromosomes & Cancer 47, 247-252 (2008).
Nasri, S., Guilford, P.et al. A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: A case control study in an Italian population. Bmc Cancer 8 (2008).
